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Abstract. 
 
There is a growing body of evidence to impli-
cate reversible tyrosine phosphorylation as an impor-
tant mechanism in the control of the adhesive function 
of cadherins. We previously demonstrated that the re-
 
ceptor protein tyrosine phosphatase PTP
 
m
 
 associates 
with the cadherin–catenin complex in various tissues 
and cells and, therefore, may be a component of such a 
regulatory mechanism (Brady-Kalnay, S.M., D.L. 
Rimm, and N.K. Tonks. 1995. 
 
J. Cell Biol.
 
 130:977–
986). In this study, we present further characterization 
of this interaction using a variety of systems. We ob-
served that PTP
 
m
 
 interacted with N-cadherin, E-cad-
herin, and cadherin-4 (also called R-cadherin) in ex-
tracts of rat lung. We observed a direct interaction 
between PTP
 
m
 
 and E-cadherin after coexpression in 
Sf9 cells. In WC5 cells, which express a temperature-
sensitive mutant form of v-Src, the complex between 
PTP
 
m
 
 and E-cadherin was dynamic, and conditions that 
resulted in tyrosine phosphorylation of E-cadherin 
were associated with dissociation of PTP
 
m
 
 from the 
complex. Furthermore, we have demonstrated that the 
COOH-terminal 38 residues of the cytoplasmic seg-
ment of E-cadherin was required for association with 
PTP
 
m
 
 in WC5 cells. Zondag et al. (Zondag, G., W. 
Moolenaar, and M. Gebbink. 1996. 
 
J. Cell Biol.
 
 134:
1513–1517) have asserted that the association we ob-
served between PTP
 
m
 
 and the cadherin–catenin com-
plex in immunoprecipitates of the phosphatase arises 
from nonspecific cross-reactivity between BK2, our an-
tibody to PTP
 
m
 
, and cadherins. In this study we have 
confirmed our initial observation and demonstrated the 
presence of cadherin in immunoprecipitates of PTP
 
m
 
 
obtained with three antibodies that recognize distinct 
epitopes in the phosphatase. In addition, we have dem-
onstrated directly that the anti-PTP
 
m
 
 antibody BK2 
that we used initially did not cross-react with cadherin. 
Our data reinforce the observation of an interaction be-
tween PTP
 
m
 
 and E-cadherin in vitro and in vivo, fur-
ther emphasizing the potential importance of reversible 
tyrosine phosphorylation in regulating cadherin func-
tion.
T
 
he
 
 cadherins are a major family of calcium-depen-
dent, homophilic cell adhesion molecules that are
concentrated at specialized contact points in the cell
termed adherens junctions (for review see Gumbiner,
1996). The cadherins are transmembrane proteins that
possess an extracellular segment, characterized by the
presence of calcium-binding motifs, and an intracellular
segment that is highly conserved between members of the
family (for review see Takeichi, 1995). The intracellular
segment serves as the site of interaction with proteins
termed catenins (
 
a
 
-, 
 
b
 
-, and 
 
g
 
-catenin) (for review see
Gumbiner, 1995). It appears that 
 
b
 
-catenin and 
 
g
 
-catenin/
plakoglobin, which are related to the product of the seg-
ment polarity gene 
 
armadillo
 
, bind directly to the cytoplas-
mic segment of cadherin, whereas 
 
a
 
-catenin, which is re-
lated to the cytoskeleton-associated protein vinculin, binds
to 
 
b
 
/
 
g
 
 catenin and functions to link the complex to the ac-
tin cytoskeleton (for review see Gumbiner, 1995). The in-
tracellular, catenin-binding segment of the cadherins is es-
sential for adhesion; mutations in this segment can disrupt
adhesion even in the presence of an intact extracellular
segment (Nagafuchi and Takeichi, 1988; Ozawa et al.,
1989). Thus, cadherin-mediated adhesion requires the in-
tact cadherin–catenin complex and association with the ac-
tin cytoskeleton.
Mutations have been detected in components of the
cadherin–catenin complex in several tumors, and destabili-
zation of cadherin-mediated adhesion has been linked
with invasion and malignant progression (for reviews see
Birchmeier and Behrens, 1994, Birchmeier, 1995). In addi-
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tion, the junctions in normal cells are dynamic and ty-
rosine phosphorylated rapidly and reversibly (Volberg et
al., 1991). There is now a growing body of evidence to link
the loss of adhesive function and the destabilization of ad-
herens junctions with changes in the state of phosphoryla-
tion of tyrosyl residues in components of the cadherin–
catenin complex (for reviews see Birchmeier and Behrens,
1994; Brady-Kalnay and Tonks, 1995). Expression of the
protein tyrosine kinase (PTK)
 
1
 
 v-Src causes aberrant ty-
rosine phosphorylation that results in disruption of adher-
ens junctions, in the absence of an effect on desmosomes
and tight junctions (Warren and Nelson, 1987). Similarly,
treatment of MDCK cells with vanadate, a broad specific-
ity inhibitor of members of the protein tyrosine phos-
phatase (PTP) family of enzymes, results in tyrosine phos-
phorylation of proteins at adherens junctions and the
deterioration of junctional structures (Volberg et al.,
1992). Furthermore, 
 
b
 
-catenin was observed to be heavily
phosphorylated on tyrosyl residues in rat fibroblasts trans-
formed by v-Src, coincident with changes in cell–cell ag-
gregation (Matsuyoshi et al., 1992). In addition, these ef-
fects were abrogated by the PTK inhibitor herbimycin A
and promoted by the PTP inhibitor vanadate. Interest-
ingly, a temperature-sensitive mutant of v-Src destabilized
cadherin-dependent adhesion at the permissive tempera-
ture, coincident with tyrosine phosphorylation of E-cad-
herin, 
 
b
 
-catenin, or cytoskeletal components (Behrens et
al., 1993; Takeda et al., 1995). The EGF receptor and
Met, the receptor for scatter factor, phosphorylate compo-
nents of the cadherin–catenin complex, and the EGF re-
ceptor has been observed to bind directly to 
 
b
 
-catenin and
to associate with the cadherin–catenin complex in epithelial
cells (Hoschuetzky et al., 1994; Ochiai et al., 1994; Shibam-
oto et al., 1994). These observations suggest that the integ-
rity of adherens junctions is regulated in part at the level
of reversible tyrosine phosphorylation that results from
the coordinated and competing actions of PTKs and PTPs.
Therefore, a prerequisite to understanding fully the signif-
icance of tyrosine phosphorylation in the control of cad-
herin–catenin function will be the identification and char-
acterization of specific PTKs and PTPs that associate with
and modify the phosphorylation status of these proteins.
In examining the physiological significance of the ty-
rosine phosphorylation of the cadherin–catenin complex,
we have obtained data that implicate the receptor PTP,
PTP
 
m
 
, as a potential regulator of this complex. PTP
 
m
 
 is
characterized by an extracellular segment that contains
one MAM (Meprin/A5/PTP
 
m
 
) domain, one immunoglob-
ulin domain, and four fibronectin type III repeats (Geb-
bink et al., 1991). This combination of motifs suggested
that PTP
 
m
 
 may function in cell–cell adhesion. In fact, we
(Brady-Kalnay et al., 1993) and others (Gebbink et al.,
1993; Sap et al., 1994) demonstrated that PTP
 
m
 
, and the
structurally related PTP
 
k
 
, participate in homophilic bind-
ing interactions. Ectopic expression of recombinant PTP
 
m
 
in Sf9 cells induces aggregation of these normally nonad-
hesive cells (Brady-Kalnay et al., 1993; Gebbink et al.,
1993). Subsequently, we determined that the homophilic
binding site within the extracellular segment of PTP
 
m
 
 re-
sides in the immunoglobulin domain (Brady-Kalnay and
Tonks, 1994). In addition, it has been shown that the
MAM domain plays a role in cell–cell aggregation possibly
by “sorting” of PTP
 
m
 
 from closely related molecules, such
as PTP
 
k
 
, during cell aggregation (Zondag et al., 1995).
More recent data suggest that one aspect of PTP
 
m
 
 func-
tion in vivo may be to affect cell adhesion by regulating
the adhesive properties of the cadherin–catenin complex.
We observed that in the MvLu lung cell line, which ex-
presses PTP
 
m
 
, catenins, and cadherins endogenously, im-
munoprecipitates of PTP
 
m
 
 contained cadherins, 
 
a
 
-catenin,
and 
 
b
 
-catenin (Brady-Kalnay et al., 1995). In fact, at least
80% of the total cellular cadherins appeared to be associ-
ated with PTP
 
m
 
 in MvLu cells. Similarly, complexes be-
tween PTP
 
m
 
 and cadherins were detected in rat heart,
lung, and brain tissues, where PTP
 
m
 
 is expressed at high
levels (Brady-Kalnay et al., 1995). The results of binding
studies in vitro suggest that this association results from a
direct interaction between the intracellular segment of
PTP
 
m
 
 and the intracellular domain of E-cadherin (Brady-
Kalnay et al., 1995). Our results raised the possibility that
a component of the cadherin–catenin complex may be an
endogenous substrate for PTP
 
m
 
. Subsequently, several
other laboratories have reported the observation of inter-
actions between cadherin–catenin complexes and both re-
ceptor and nontransmembrane PTPs in a variety of cell
systems (Balsamo et al., 1996; Fuchs et al., 1996; Kypta et
al., 1996; Aicher et al., 1997; Cheng et al., 1997).
In this paper, we report the results of a further charac-
terization of the association between PTP
 
m
 
 and cadherin–
catenin complexes. We have identified the cadherins that
associate with PTP
 
m
 
 in vivo from lysates of rat lung as
N-cadherin, E-cadherin, and cadherin-4 (also called R-cad-
herin). We have used a number of systems to characterize
further the association of PTP
 
m
 
 and E-cadherin and have
demonstrated that the COOH-terminal 38 residues of the
cytoplasmic segment of E-cadherin is necessary for bind-
ing of PTP
 
m
 
. Furthermore, we have shown that conditions
that result in tyrosine phosphorylation of E-cadherin also
result in dissociation of PTP
 
m
 
 from the complex. A recent
article from Zondag et al. (1996) argues that PTP
 
m
 
 does
not associate with cadherins and suggests that our obser-
vations are the result of nonspecific cross-reactivity be-
tween BK2, our antipeptide antibody to PTP
 
m
 
, and cad-
herins. We present several lines of data to substantiate the
validity of our original observation of the association be-
tween PTP
 
m
 
 and the cadherin–catenin complex and to re-
fute the assertion of Zondag et al. that our observation
arises from nonspecific antibody cross-reactivity.
 
Materials and Methods
 
Expression Vectors and Cell Lines
 
Expression vectors for wild-type and mutant murine E-cadherins were ei-
ther generously provided by Masatoshi Takeichi (Kyoto University, Ja-
pan) (Nagafuchi and Takeichi, 1988; Nose et al., 1988) or described in
Chen et al. (1997). WC5 cells were derived from neonatal rat cerebellar
cells by transformation with a mutant of Rous sarcoma virus (LA90) that
is temperature-sensitive for transformation (Giotta and Cohn, 1981). At
the permissive temperature, 33
 
8
 
C, v-Src is active as a PTK, and the cells are
transformed. At 39
 
8
 
C, the v-Src PTK is relatively inactive, and the cells
display an epithelial morphology. WC5 cells were maintained at 33
 
8
 
C in
DME (GIBCO BRL, Gaithersburg, MD) containing 10% fetal bovine se-
 
1. 
 
Abbreviations used in this paper
 
: GST, glutathione S transferase; PTK,
protein tyrosine kinase; PTP, protein tyrosine phosphatase.
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rum and 10 
 
m
 
g/ml gentamicin. The isolation of stable cell lines expressing
full-length and deletion constructs of E-cadherin has been described
(Chen et al., 1997). At least two clonal cell lines for each E-cadherin dele-
tion mutant were tested in each of the experiments described. MvLu cells
were cultured as described previously (Brady-Kalnay et al., 1995). The
cell line MCF10AneoN was generously provided by Bonnie Sloan (Wayne
State University, Detroit, MI) and cultured as described in Kinch et al.
(1997). Sf9 cells (CRL 1711; American Type Culture Collection, Rock-
ville, MD) were maintained at 27
 
8
 
C in Grace’s Insect Medium Supple-
mented (GIBCO BRL) containing 10% fetal bovine serum and 10 
 
m
 
g/ml
gentamicin.
 
Expression in Sf 9 Cells
 
The following recombinant baculoviruses were used: (
 
a
 
) expressing full-
length PTP
 
m
 
, described previously (Brady-Kalnay et al., 1993); (
 
b
 
) ex-
pressing E-cadherin, generated using the BaculoGold Transfection Sys-
tem (Invitrogen Corp., Carlsbad, CA) after ligation of a full-length 2.7-kb
cDNA (recovered by restriction digestion of the pBATEM2 plasmid, gen-
erously provided by M. Takeichi) into pVL1392 (Invitrogen Corp.); and
(
 
c
 
) expressing 
 
b
 
-catenin, generously provided by R. Kypta (University of
California, San Francisco, CA). Sf9 cells were infected with the recombi-
nant baculoviruses either singly or in pairwise combinations as previously
described (Brady-Kalnay et al., 1993). Cells were harvested 48 h after in-
fection by centrifugation at 3,000 
 
g
 
 for 5 min and processed for immunopre-
cipitation and immunoblotting as described below.
 
Antibodies
 
Hybridoma cells expressing a rat monoclonal antibody against the extra-
cellular domain of E-cadherin, ECCD-2 (Shiroyashi et al., 1986), were
generously provided by Masatoshi Takeichi. Conditioned medium from
these cells was used in our experiments. A mouse monoclonal antibody to
E-cadherin, antibodies to 
 
b
 
-catenin, and antiphosphotyrosine antibody
(PY20) were purchased from Transduction Labs (Lexington, KY). In the
course of our experiments involving antibody recognition of E-cadherin
fusion proteins, we determined that the anti–E-cadherin antibody from
Transduction Labs recognized the juxtamembrane half of the intracellular
segment. Pan-cadherin antibodies (monoclonal and polyclonal), which re-
act with the conserved COOH-terminal 24 amino acids of the cadherin cy-
toplasmic segment, were purchased from Sigma Chemical Co. (St. Louis,
MO). The cadherin-4 antibody (120A) was generously provided by ICOS
Corp. (Seattle, WA). Antibody to N-cadherin (BD7873) was generously
provided by Dr. J. Hemperly at Becton Dickinson Labs (Res. Triangle
Park, NC) and has been described previously (Payne et al., 1996). Mono-
clonal antibodies to the intracellular segment of PTP
 
m
 
 (SK series) and
monoclonal antibody BK-2, generated against a peptide derived from the
extracellular segment of PTP
 
m
 
, have been described previously (Brady-
Kalnay et al., 1993; Brady-Kalnay and Tonks 1994). Polyclonal antibodies
to glutathione S transferase (GST) (Brady-Kalnay et al., 1995) and the
FG6 monoclonal antibody to PTP1B (Flint et al., 1993) have been de-
scribed previously.
 
Binding Assays In Vitro
 
The GST fusion protein of the extracellular segment of PTP
 
m
 
 (EXTRA-
PTP
 
m
 
) has been described previously (Brady-Kalnay et al., 1993). Two
GST/E-cadherin fusion proteins were generated that contain either amino
acids 572–631 (the juxtamembrane-half of the cytoplasmic segment, JM
E-cad) or amino acids 648–729 (the COOH-terminal, catenin-binding por-
tion of the intracellular segment, CB E-cad). Proteins were expressed in
 
Escherichia coli
 
 and purified using glutathione Sepharose (Brady-Kalnay
et al., 1995). In slot blot analyses, purified protein samples were adsorbed
to nitrocellulose mounted in a slot blot apparatus (Bio-Rad Laboratories,
Hercules, CA). The nitrocellulose strip was blocked in 5% nonfat dry milk
in TTBS (20 mM Tris-Cl, pH 7.5, 660 mM NaCl, 0.05% Tween-20) and
then incubated with primary antibody for 16 h at 4
 
8
 
C. The blot was
washed in TTBS and then developed using horseradish peroxidase–conju-
gated secondary antibodies and Enhanced Chemiluminescence reagents
(Amersham Corp., Arlington Heights, IL).
 
Preparation of Samples for Immunoprecipitation
 
Triton-soluble lysates of rat lung and MvLu cells were prepared as de-
scribed (Brady-Kalnay et al., 1995). WC5 cells were lysed in 20 mM Tris,
pH 7.5, 2 mM CaCl
 
2
 
, 1% Triton X-100, 5 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml aproti-
 
nin, 1 mM benzamidine, 200 
 
m
 
M phenyl arsine oxide, 1 mM vanadate, and
0.1 mM molybdate).
 
 
 
The buffer was supplemented with 150 mM NaCl for
lysis of Sf9 cells. For immunoprecipitation, antibodies were incubated with
protein A or protein G beads (Pharmacia Biotech, Piscataway, NJ) for 2 h
at room temperature and then washed three times with PBS (9.5 mM
phosphate, 137 mM NaCl, pH 7.5) before addition to cell lysates. Purified
monoclonal antibodies were used at 0.6 mg of IgG/ml beads, ascites fluid
was used at 1 mg of IgG/ml beads, and polyclonal serum was used at 3 mg
of IgG/ml beads. Immunoprecipitates were prepared from 200–400 
 
m
 
g of a
Triton-soluble lysate of WC5 cells. The immunoprecipitates were washed
four times in lysis buffer,
 
 
 
and the bound material was eluted by addition of
100 
 
m
 
l of 2
 
3
 
 sample buffer and heating for 5 min at 95
 
8
 
C. The proteins
were separated by electrophoresis on 6 or 8% SDS polyacrylamide gels and
transferred to nitrocellulose or polyvinyl difluoride for immunoblotting.
 
Results
 
PTP
 
m
 
 Interacts with Distinct Members of the
Cadherin Superfamily
 
In our initial paper (Brady-Kalnay et al., 1995), we re-
ported that immunoprecipitates of PTP
 
m
 
 from lysates of
MvLu cells contained components of the cadherin–catenin
complex. Our data indicated that at least 80% of the cad-
herin in MvLu cell lysates was cleared after immunopre-
cipitation with antibodies to PTP
 
m
 
. These results have
been called into question (Zondag et al., 1996). To address
the reproducibility of this observation, we performed a se-
ries of immunoprecipitations from lysates of MvLu cells.
We used two different concentrations of anti-PTP
 
m
 
 anti-
body BK2 or an isotype-matched antibody, FG6, to an un-
related PTP, PTP1B (Flint et al., 1993) as a negative con-
trol. In addition, the pan-cadherin antibody and an antibody
to 
 
b
 
-catenin were included as two positive controls. The
relative amounts of antibody heavy chain in each immuno-
precipitate are shown in Fig. 1 
 
A
 
. The anti-PTP
 
m
 
 antibody
BK2 coimmunoprecipitated cadherin from MvLu cell ly-
sates, to an extent comparable to that seen with the anti-
cadherin and anti–
 
b
 
-catenin antibodies. In contrast, the
isotype-matched control antibody to PTP1B did not im-
munoprecipitate cadherin from MvLu cells at either con-
centration (Fig. 1 
 
B
 
). In addition, after immunoprecipita-
tion with the various antibodies, we immunoblotted the
supernatant that remained to determine the quantity of
cadherin that was not precipitated. The results were in
agreement with the recovery of cadherin in the immuno-
precipitates (Fig. 1 
 
B
 
). Cadherin was cleared from the ly-
sates by immunoprecipitation with anti-PTP
 
m antibody
BK2, to a similar extent as observed in the two positive
control immunoprecipitates with pan-cadherin and anti–
b-catenin antibodies (Fig. 1 C). These data confirm that
the majority of cadherin can be recovered in a complex
with PTPm from MvLu cell lysates. In contrast, control
anti-PTP1B antibodies did not clear cadherin from the su-
pernatant (Fig. 1 C).
To identify specific cadherins that associate with PTPm,
we performed a series of experiments using extracts of rat
lung that express PTPm endogenously. Immunoprecipi-
tates of PTPm from rat lung extracts contained three major
types of cadherins that were recognized by the pan-cad-
herin antibody (Fig. 2, arrows). Using antibodies to spe-
cific cadherin family members, we determined that PTPm
associated with N-cadherin, E-cadherin, and cadherin-4
(also known as R-cadherin) (Fig. 2).
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Reconstitution of the Interaction between PTPm
and E-cadherin in Sf9 Cells 
A major contention of the paper by Zondag et al. (1996)
was that the association we observed between PTPm and
cadherin was an artifact arising from nonspecific cross-
reactivity between the anti-PTPm antibody, BK2, and cad-
herins. We have now addressed this issue in a variety of
systems.
We have reconstituted the complex in Sf9 cells by ex-
pression of the individual components using recombinant
baculoviruses. PTPm, E-cadherin, and b-catenin were ex-
pressed singly or in pairwise combinations, and expression
was verified by immunoblotting cell lysates with the ap-
propriate antibodies (Fig. 3, Lysate). E-cadherin was re-
covered in anti-PTPm immunoprecipitates, prepared using
the BK2 antibody, only from cells in which both proteins
were coexpressed (Fig. 3, BK2 IPs, Ecadherin blots, lane
4). The BK2 antibody did not precipitate E-cadherin from
cell lysates in the absence of PTPm, thus ruling out the pos-
sibility that the antibody recognized E-cadherin nonspecif-
ically (Fig. 3, BK2 IPs, Ecadherin blots, lane 2). Similar
observations were made when we examined immunopre-
cipitates with the anti-PTPm antibody BK2 from lysates of
MCF-10A cells, which express large amounts of E-cad-
herin but do not express detectable levels of PTPm. Even
in the presence of substantial quantities of E-cadherin and
the inclusion of large quantities of the antibody, BK2 did
not precipitate E-cadherin from lysates of MCF10A cells
(data not shown). When the experiment was repeated us-
ing a distinct antibody to PTPm, SK18, which recognizes
an epitope in the intracellular portion of the enzyme, the
same observation was made. E-cadherin was recovered in
anti-PTPm immunoprecipitates only from lysates of cells
coexpressing the phosphatase together with E-cadherin
and not cells expressing E-cadherin alone (Fig. 3, SK18 IPs).
Furthermore, the formation of a complex was also re-
vealed by the reverse immunoprecipitation/blotting strat-
egy, in that PTPm was recovered in immunoprecipitates of
E-cadherin, but only from lysates of cells in which both
proteins were expressed (Fig. 3, Ecad IPs, PTPm blots,
lane 4).
The data also illustrate that PTPm did not interact with
b-catenin in this system (see Fig. 3, anti–b-catenin blots of
BK2 and SK18 immunoprecipitates and anti-PTPm blots
of b-catenin immunoprecipitates), whereas b-catenin was
recovered in immunoprecipitates of E-cadherin (Fig. 3,
Ecad IPs and b cat IPs), indicating that the protein was
produced in a conformation appropriate for complex for-
mation. This observation is consistent with our previous
results from blot-overlay assays, which revealed a direct
interaction between PTPm and E-cadherin in vitro (Brady-
Kalnay et al., 1995) and indicates that the binding of PTPm
to E-cadherin is not mediated by b-catenin.
These data reveal that PTPm/E-cadherin complexes are
recovered by immunoprecipitation with two distinct anti-
bodies to the phosphatase or with antibody to E-cadherin.
In addition, anti-PTPm antibodies did not precipitate E-cad-
Figure 1. Coimmunoprecipitation of PTPm and cadherin from ly-
sates of MvLu cells. Lysates of MvLu cells were subjected to im-
munoprecipitation with two different concentrations of anti-
PTPm antibody BK2 or an isotype-matched antibody to PTP1B
(FG6), as well as the pan-cadherin and anti–b-catenin antibody.
The relative amounts of antibody heavy chain in each immuno-
precipitate are shown in a Ponceau S stain of the immunoblot
(A). Immunoblots using pan-cadherin antibody were performed
on the immunoprecipitates (B). The quantity of cadherin remain-
ing in the supernatant after immunoprecipitation was assessed by
immunoblotting (C). The results illustrate that the majority of
cadherin in the lysate coimmunoprecipitated with PTPm.
Figure 2. Association of PTPm with N-cadherin, E-cadherin, and
cadherin-4 in extracts of rat lung. Extracts of rat lung were immu-
noprecipitated with mouse IgG (first lane) or BK2 antibody to
PTPm (second lane). These immunoprecipitates were immuno-
blotted and probed with the pan-cadherin antibody, the N-cad-
herin antibody, the E-cadherin antibody, or antibody to cadherin-4.
Arrows indicate the position of the three bands detected with the
pan-cadherin antibody. The data indicate that PTPm interacts
with three distinct members of the cadherin family.
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herin in the absence of the phosphatase. Therefore, it is
highly unlikely that this result could be explained by non-
specific antibody cross-reactivity.
The PTPm/E-cadherin Complex Is Dynamic In Vivo
WC5 is a Rous sarcoma virus–transformed, rat cerebellar
cell line that expresses a temperature-sensitive mutant of
the v-Src PTK. When grown at the nonpermissive temper-
ature (398C), the Src PTK displays little activity, and the
cells manifest properties of astrocytes (Giotta and Cohn,
1981). In contrast, when grown at the permissive tempera-
ture (338C), Src is active and the cells are transformed.
The expression of endogenous PTPm, both the unproc-
essed (200 kD) and proteolytically processed (100 kD)
forms of the enzyme, and ectopically expressed E-cad-
herin was not affected by switching between permissive
and nonpermissive temperatures (Fig. 4 A).
We used the WC5 cell line that expresses full-length E-cad-
herin to assess the effect of tyrosine phosphorylation on
the PTPm/cadherin complex by comparing the extent to
which E-cadherin coimmunoprecipitated with PTPm at the
permissive and nonpermissive temperatures. As shown in
Fig. 4, PTPm antibodies coimmunoprecipitated E-cadherin
well at the nonpermissive temperature (398C) but poorly
at the permissive temperature (338C) for the Src PTK (Fig.
4 B), despite the fact that expression of E-cadherin was ap-
parently unaltered at 398C compared with 338C (Fig. 4 A).
Interestingly, E-cadherin was immunoprecipitated with
antiphosphotyrosine antibodies at 338C but to a lesser ex-
tent at 398C. Under harsh detergent conditions (RIPA
buffer), we observed that E-cadherin was tyrosine phos-
phorylated directly at the permissive temperature (data
not shown). Therefore, our data indicate an inverse corre-
lation between the presence of PTPm in the cadherin–cate-
nin complex and the phosphorylation of tyrosyl residues in
E-cadherin. The fact that a complex between PTPm and
E-cadherin was detected at 398C but not at 338C, using
identical conditions for cell lysis and immunoprecipitation
at each temperature, indicates that the complex we ob-
serve is dynamic. Furthermore, although the potential ex-
istence of a phosphorylation-sensitive, cross-reacting
epitope is not formally excluded, these data also indicate
that it is unlikely that the complex we detect can be ex-
plained by nonspecific antibody cross-reactivity.
Identification of the Catenin-binding Domain within 
the Intracellular Segment of E-cadherin as the Site of 
Interaction with PTPm
In our previous study, we demonstrated that E-cadherin
interacts with PTPm both in vitro and in vivo. Therefore,
Figure 3. Reconstitution of the in-
teraction between PTPm and E-cad-
herin in Sf9 cells. Using recombinant
baculoviruses, PTPm, E-cadherin,
and b-catenin were expressed singly
(lane 1–3, respectively) or in pair-
wise combinations, PTPm 1 E-cad-
herin (lane 4), PTPm 1 b-catenin
(lane 5), and E-cadherin 1 b-cate-
nin (lane 6) in Sf9 cells. Cells were
lysed, and 1 mg of lysate protein was
blotted directly to confirm expres-
sion of the individual proteins. PTPm
was expressed primarily in the full-
length form that was not proteolyti-
cally processed. Immunoprecipitates
were prepared from 40 mg of cell ly-
sate using the antibodies indicated
on the left of the figure and blotted
with either anti-PTPm antibody SK15
anti–E-cadherin antibody ECCD-2,
or anti–b-catenin antibody (Trans-
duction Labs), as indicated across
the top of the figure.  o
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we set out to identify the binding site for PTPm in E-cad-
herin. In our initial report, we demonstrated that the intra-
cellular segment of PTPm interacted directly with the in-
tracellular segment of E-cadherin (Brady-Kalnay et al.,
1995). To determine more precisely the location of the
PTPm-binding site within the cytoplasmic segment of E-cad-
herin, we used the WC5 cells, which express PTPm endog-
enously but do not express endogenous E-cadherin. We
used a series of WC5 cell lines that express ectopically var-
ious forms of E-cadherin containing deletions in the cyto-
plasmic segment. We tested for the effects of the deletions
in E-cadherin on its ability to associate with PTPm in a cel-
lular context by immunoprecipitating PTPm from the vari-
ous WC5 cell lysates and determining whether E-cadherin
coimmunoprecipitated with the phosphatase. As shown in
Fig. 5 A, WC5 cell lines expressing five deletion mutants of
E-cadherin (Chen et al., 1997) were used. Specifically,
these included (a) the full-length E-cadherin molecule as a
control (Ecad), (b) a control from which the entire cyto-
plasmic segment of E-cadherin was deleted (CDD), (c) a
mutant in which the COOH-terminal 38 residues were de-
leted (CB), (d) a mutant in which the internal domain of
the intracellular segment was deleted (ID), and (e) a mu-
tant in which the juxtamembrane domain of E-cadherin
was deleted (JM).
The WC5 cell lines expressed each of the E-cadherin de-
letion mutants to similar levels. Each of the mutants was
precipitated with antibodies to the extracellular segment
of E-cadherin and migrated at the expected molecular
weight (Fig. 5 B). A monoclonal antibody to the cytosolic
PTP, PTP1B (Flint et al., 1993), was used as a negative
control, and although capable of immunoprecipitating
PTP1B (data not shown), it did not immunoprecipitate
E-cadherin (Fig. 5 C). Using the BK2 antibody to PTPm,
which recognizes a peptide sequence in the MAM domain
within the extracellular segment of PTPm (Brady-Kalnay
and Tonks, 1994), we observed that E-cadherin mutants
bearing a deletion of the COOH-terminal 38 amino acids
did not associate with PTPm (Fig. 5 D). Thus, PTPm failed
to coimmunoprecipitate E-cadherin from two distinct
WC5 lines expressing such E-cadherin deletion mutants
(CB1 and CB2) and from a line expressing E-cadherin
from which the entire cytoplasmic segment was deleted
(CDD). These results indicate that the COOH-terminal 38
residues of E-cadherin is required for the interaction with
PTPm.
Originally, our observation of association between
PTPm and cadherin was founded primarily upon experi-
ments performed with one antibody to the phosphatase,
designated BK2, which recognized an epitope in the extra-
cellular segment of the enzyme. We generated previously
the SK series of monoclonal antibodies to the intracellular
domain of PTPm (Brady-Kalnay et al., 1993). By using his-
tidine-tagged fusion proteins comprising various portions
of the intracellular segment of PTPm, we identified two
classes of SK antibodies. One class recognized epitopes in
the juxtamembrane segment of the phosphatase whereas
the other recognized epitopes in the first phosphatase do-
main (data not shown). To extend the scope of our analy-
sis of the association of PTPm and cadherins, we tested
whether the SK series monoclonal antibodies were able to
immunoprecipitate the PTPm/E-cadherin complex from
the various WC5 cell lines, concentrating on one with an
epitope in the juxtamembrane segment of PTPm (SK7)
and another that recognized the first PTP domain (SK18).
As shown in Fig. 5, E and F, these antibodies, like BK2,
immunoprecipitated the PTPm/E-cadherin complex, but
only from cells expressing forms of E-cadherin in which
the COOH-terminal 38 residues were present. Similar
data were obtained with all SK series antibodies tested
(data not shown).
The Anti-PTPm Antibody, BK2, Does Not Cross-react 
with Cadherins
The BK2 antibody was generated against a peptide de-
rived from the NH2 terminus of human PTPm (Brady-Kal-
nay et al., 1994) and did not show cross-reactivity with the
PTPm-like enzymes PTPk and PTPl/PCP-2. The peptide
sequence displayed no obvious similarity to the intracellu-
lar segment of cadherin, which contains the site of interac-
tion with PTPm (Brady-Kalnay et al., 1995 and Fig. 5). De-
spite the lack of obvious sequence similarity between this
peptide and the cadherins, we addressed the issue of cross-
reactivity further in the following experiment.
We examined whether the anti-PTPm antibody BK2 rec-
ognized a GST–E-cadherin fusion protein, purified after
expression in E. coli, in a direct binding assay under non-
denaturing conditions in vitro. Our original study demon-
strated an interaction between the intracellular segment of
PTPm and the intracellular segment of E-cadherin (Brady-
Kalnay et al., 1995). Furthermore, the data presented here
in Fig. 5 show that the COOH-terminal 38 residues of
E-cadherin were required for association with PTPm.
Therefore, any potential cross-reacting epitopes would be
in this segment. We tested whether the BK2 antibody
binds to the intracellular segment of E-cadherin under
nondenaturing conditions. We used the following four
GST fusion proteins: (a) GST alone, (b) the juxtamem-
brane half of the intracellular segment of E-cadherin (JM
E-cad), (c) the COOH-terminal, catenin-binding portion
Figure 4. Inverse correlation
between tyrosine phosphory-
lation of E-cadherin and as-
sociation with PTPm. (A) Im-
munoblots of lysates of WC5
cells ectopically expressing
full-length E-cadherin grown
at either 39 or 338C. The left
panel shows a blot with anti-
PTPm antibody SK15, and the
right panel shows a blot with
ECCD-2 antibody to E-cad-
herin. The data illustrate that
the levels of PTPm and E-cad-
herin are unaltered by the
shift in temperature. (B) Im-
munoprecipitates of WC5 cell
lysates prepared in Triton-
containing buffer, using ei-
ther anti-PTPm antibody BK2
or antiphosphotyrosine anti-
body PY20. The immunoprecipitates were blotted with the
ECCD-2 antibody to E-cadherin.
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of the intracellular segment of E-cadherin (CB E-cad),
and (d) the extracellular domain of PTPm (EXTRA
PTPm). An antibody to GST recognized all of the fusion
proteins (Fig. 6 A). One of the commercially available anti-
bodies reacted with the juxtamembrane half of E-cadherin
(Fig. 6 B), whereas the polyclonal, pan-cadherin antibody
reacted with the catenin-binding half of the E-cadherin in-
tracellular segment (Fig. 6 C). The SK15 antibody, to the
intracellular segment of PTPm, did not recognize any of
the fusion proteins (Fig. 6 D), whereas antibody BK2 in-
teracted only with the extracellular segment of PTPm (Fig.
6 E). Thus, under these conditions, the BK2 antibody did
not recognize the intracellular segment of E-cadherin,
which contains the binding site for PTPm (Fig. 5), even
when 10 mg of the purified protein was applied to the ni-
trocellulose filter to ensure maximal binding of the protein
to the nitrocellulose, and the blot was overexposed. These
data provide further indication that the BK2 antibody
does not recognize E-cadherin nonspecifically.
Discussion
Components of adherens junctions are subjected to rapid,
reversible tyrosine phosphorylation in a cellular context
(Volberg et al., 1991). Tyrosine phosphorylation of the
cadherin–catenin complex has been observed under a vari-
ety of conditions, including in response to oncoprotein
PTKs, such as Src (Matsuyoshi et al., 1992; Behrens et al.,
1993), or to oncogenic forms of Ras (Kinch et al., 1995)
and following stimulation of receptor PTKs, such as EGF
receptor and Met (Shibamoto et al., 1994). In addition,
PTKs such as EGF receptor and c-erbB2 have been ob-
served to associate with the cadherin–catenin complex in
vivo (Hoschuetzky et al., 1994; Ochiai et al., 1994). The re-
versibility of tyrosine phosphorylation in vivo depends
upon the coordinated action of both PTKs and PTPs.
Therefore, to understand fully the regulation of cadherin
function by reversible tyrosine phosphorylation, it will be
necessary to identify and characterize the phosphatases
that act upon adhesion complexes in vivo. Our observation
of association between a receptor PTP, PTPm, and cad-
herins in various tissues and cells is consistent with a role
for this phosphatase in regulating cadherin function and
lends further support to the regulatory importance of ty-
rosine phosphorylation in cell adhesion.
In this study, we have demonstrated that PTPm inter-
Figure 5. Identification of the seg-
ment of E-cadherin that is required
for interaction with PTPm. (A)
Schematic diagram of the E-cad-
herin mutants that were expressed
ectopically in the WC5 cell line. In
addition to wild-type E-cadherin,
there were mutants containing the
following deletions: the entire cyto-
plasmic segment (CDD), the catenin
binding domain (CB), the internal
domain (ID), or the juxtamem-
brane domain (JM). B–F illustrate a
series of immunoprecipitates that
have been blotted with the ECCD-2
antibody to the extracellular seg-
ment of E-cadherin. (B) E-cadherin
(ECCD-2). All the E-cadherin de-
letion mutants were expressed to
similar levels and migrated at the
appropriate molecular weight. (C)
PTP1B (FG6). (D) PTPm (BK2).
(E) PTPm (SK7). (F) PTPm (SK18).
These results illustrate that only
forms of E-cadherin that contain
the COOH-terminal, catenin-bind-
ing domain associated with PTPm.
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acted with N-cadherin, E-cadherin, and cadherin-4 (also
called R-cadherin) in extracts of rat lung. Although PTPm
can interact with several cadherins, it displays a restricted
tissue distribution. Therefore, one would anticipate that, if
regulation of cadherin function by reversible tyrosine
phosphorylation was a general phenomenon, there would
be additional PTPs that function in a manner analogous to
PTPm in other cell types. Subsequent to our original dem-
onstration of association between PTPm and the cadherin–
catenin complex (Brady-Kalnay et al., 1995), several re-
ports have appeared that substantiate the general principle
that members of the PTP family may be important regula-
tors of cadherin-mediated adhesion. Association of a num-
ber of receptor and nontransmembrane PTPs with differ-
ent members of the cadherin family in a variety of cell
systems has now been reported. PTPk, a receptor PTP that
is closely related in structure to PTPm (z75% sequence
identity with the same overall arrangement of structural
motifs), has been shown to associate directly with b-cate-
nin and plakoglobin (Fuchs et al., 1996). Interestingly,
PTPk displays a much broader expression pattern than
PTPm (Jiang et al., 1993) and therefore may interact with
cadherin–catenin complexes in many tissues. To date, four
other PTPs have been shown to interact with cadherin–
catenin complexes. Most recently, LAR (Aicher et al.,
1997) and a novel receptor PTP, termed PTPl (a close rel-
ative of PTPs m and k; Cheng et al., 1997), were also shown
to associate with b-catenin. These authors observed that
the association with b-catenin, like that involving PTPk
(Fuchs et al., 1996), required the intracellular segment of
the phosphatase (Aicher et al., 1997; Cheng et al., 1997). A
LAR-like receptor PTP was found to associate with the
cadherin–catenin complex in PC12 cells, and this associa-
tion appears to be regulated by nerve growth factor–induced
tyrosine phosphorylation of the PTP itself (Kypta et al.,
1996). In addition, a PTP1B-like cytoplasmic phosphatase
has been shown to interact with N-cadherin (Balsamo et
al., 1996). The authors suggest that the association of the
PTP with N-cadherin facilitates dephosphorylation of
b-catenin, which is required for N-cadherin–mediated ad-
hesion and its association with the actin cytoskeleton.
In contrast to this consensus view of the potential im-
portance of PTPs in regulating the tyrosine phosphoryla-
tion of cadherin–catenin complexes in vivo, one report
(Zondag et al., 1996) has questioned the validity of our
original observation. Therefore, we will respond in detail
to the various issues raised in the paper by Zondag et al.,
in an attempt both to resolve this controversy and clarify
the various issues. Zondag et al. report the generation of
antibodies to an undefined epitope(s) in the ectodomain
of PTPm that fail to coimmunoprecipitate cadherin–cate-
nin complexes. After successive rounds of immunoprecipi-
tation with one of these antibodies, 3D7, to “clear” PTPm
from the cell lysate, the authors subjected the cleared ly-
sate to immunoprecipitation with our antibody BK2. Even
though they were unable to detect PTPm in the cleared ly-
sate by immunoblotting with their antibodies, they still ob-
served cadherin in BK2 immunprecipitates. From this, the
authors concluded that the interaction we observed was
due to nonspecific cross-reactivity between BK2 and cad-
herin. There are two problems with this experiment and
the conclusion drawn from it. Firstly, the authors did not
blot the cleared lysate with BK2 to check whether there
was a pool of PTPm that was not recognized by their anti-
bodies but was detected by BK2. Secondly, although the
authors made the strong assertion of nonspecific cross-
reactivity between BK2 and cadherin, they failed to dem-
onstrate such cross-reactivity in a direct binding assay.
The following observations refute their argument. First,
we used Sf9 cells, which do not contain detectable levels of
endogenous PTPm or E-cadherin, to express these pro-
teins and reconstitute the complex. Through this approach
we demonstrated that E-cadherin was only recovered in
immunoprecipitates of PTPm from lysates of cells in which
both proteins had been coexpressed. Furthermore, the
complex was detected in the reciprocal experiment, in which
PTPm was recovered in immunoprecipitates of E-cad-
herin, but again only from lysates of cells in which both
proteins had been coexpressed. Second, and importantly,
BK2 did not recognize E-cadherin in a direct binding assay
in vitro, using purified components under nondenaturing
conditions. Third, BK2 did not immunoprecipitate E-cad-
herin from lysates of MCF10A cells, which do not express
PTPm to a level that can be detected by antibody BK2 but
express substantial levels of E-cadherin. The authors
present data from a similar experiment in COS cells, which
they state lacks endogenous PTPm. They report that cad-
herin is detected in BK2 immunoprecipitates whether or
not PTPm was expressed ectopically. However, using a
number of antibodies to PTPm, including BK2, we de-
tected expression of this protein in COS cells (data not
shown), and thus coprecipitation of cadherin would not be
unexpected. The reason for this discrepancy is unclear, al-
though the authors did not test for the presence of PTPm
in COS cell lysates by blotting with BK2. Fourth, in WC5
cells transformed by temperature-sensitive v-Src and ex-
pressing E-cadherin ectopically, immunoprecipitates of
PTPm from lysates of cells cultured at the nonpermissive
temperature contained coprecipitating cadherin, whereas
Figure 6. The BK2 antibody
does not cross-react with the
intracellular segment of E-cad-
herin. Purified GST fusion
proteins (2, 5, or 10 mg) were
applied to the wells of a slot
blot apparatus and adsorbed
to nitrocellulose. Identical
nitrocellulose strips were in-
cubated with antibodies to
(A) GST, (B) the juxtamem-
brane half of the intracellular
segment of E-cadherin (Trans-
duction Labs), (C) the cate-
nin-binding half of the intra-
cellular segment of E-cadherin
(Sigma pan-cadherin), (D)
antibody to the intracellular
segment of PTPm (SK15), or
(E) the BK2 antibody the ex-
tracellular segment of PTPm.
The data illustrate that the
BK2 antibody does not cross-react with the intracellular segment
of E-cadherin, which is the portion of E-cadherin required for as-
sociation with PTPm.
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at the permissive temperature the levels of associated cad-
herin were reduced substantially (Fig. 4). It is unlikely that
BK2 would display cross-reactivity only in lysates from
one temperature condition. Finally, we have demonstrated
interaction between PTPm and various members of the
cadherin family using different antibodies that recognize
at least three distinct epitopes in the phosphatase.
Zondag et al. (1996) presented several additional argu-
ments to question the validity of the association we ob-
served between PTPm and cadherin. For example, they
cited their failure to detect the phosphatase in anticad-
herin immunoprecipitates as further evidence that PTPm
and cadherin do not interact. However, it is important to
note that in these experiments the authors used a pan-cad-
herin antibody that is directed against the COOH-termi-
nal sequence that contains the segment of E-cadherin that
is required for interaction with PTPm. Therefore, the ab-
sence of PTPm from these immunoprecipitates could eas-
ily be explained by steric hindrance introduced by anti-
body binding to cadherin. In addition, the authors dismiss
our demonstration of direct interaction in blot-overlay
binding studies as the result of production of the cadherin
and PTPm fusion proteins in bacteria, which, they suggest,
is likely to yield misfolded or denatured protein and result
in a high risk of nonspecific protein–protein interactions.
However, the PTPm used as probe was produced in insect
Sf9 cells, not bacteria, and was catalytically functional and
therefore was not denatured or misfolded. Furthermore,
we included controls in the experiment to show that, as
would be expected, under identical conditions E-cadherin
bound b-catenin (specifically the NH2-terminal segment
and not the COOH-terminal segment of b-catenin) but
not a-catenin. Therefore, it is unlikely that our results can
be explained by nonspecific association or improper pro-
tein folding.
The observation that PTPm could interact with several
cadherins prompted us to investigate the binding site for
PTPm on the cadherins. For these studies, we used a series
of WC5 rat astrocyte-like cell lines, which express PTPm
endogenously and express ectopically mutant forms of
E-cadherin that lacked various portions of the cytoplasmic
segment. The results indicated that the COOH-terminal
38 residues, which overlap with the catenin-binding do-
main, were required for the interaction with PTPm. A
number of factors suggest that this is likely to be a direct
binding site: (a) We have demonstrated previously that the
intracellular segment of PTPm interacts directly with the
intracellular segment of E-cadherin in vitro; (b) we have
shown here (Fig. 3) that PTPm and E-cadherin interact af-
ter coexpression in Sf9 cells and, considering the extent of
overexpression achieved in this system, it is unlikely that
the interaction is mediated by an endogenous Sf9 cell pro-
tein; and (c) deletions of other portions of the E-cadherin
cytoplasmic segment had little effect on the association
with PTPm in WC5 cells. Although we did not detect a di-
rect interaction between PTPm and b-catenin in vitro or in
Sf9 cells, we have detected both cadherin and b-catenin in
immunoprecipitates of PTPm (Brady-Kalnay et al., 1995).
In light of data suggesting that E-cadherin functions as a
dimer (Brieher et al., 1996; Nagar et al., 1996), it is possi-
ble that one E-cadherin molecule of the dimer may bind
PTPm while the other interacts with b-catenin. The obser-
vation that the COOH-terminal 38 residues of E-cadherin
are required for interaction with PTPm raises the possibil-
ity that the association may be regulated by b-catenin in
vivo.
In summary, we believe that our data have established
convincingly the existence of a complex between PTPm
and various members of the family of cadherins in a num-
ber of different cell systems. In addition, we believe that
we have presented data to refute convincingly the asser-
tions of Zondag and colleagues (1996) that the association
we observe between PTPm and cadherins is artifactual.
Our observations highlight further the potential impor-
tance of reversible tyrosine phosphorylation in regulating
the adhesive properties of the cadherin family of cell adhe-
sion molecules.
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